Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Journal of Molecular Endocrinology|June 2, 2017
5-ALA ameliorates hepatic steatosis through AMPK signaling pathwayHaoyong Yu, Mingliang Zhang, Yunqin Ma, et al.Metabolism: Clinical and Experimental|July 5, 2019
Activation of G0/G1 switch gene 2 by endoplasmic reticulum stress enhances hepatic steatosisYunqin Ma, Mingliang Zhang, Haoyong Yu, et al.Journal of Translational Medicine|July 20, 2024
USP13 ameliorates nonalcoholic fatty liver disease through inhibiting the activation of TAK1Min Tang, Han Cao, Yunqin Ma, et al.Diabetes & Metabolism|June 22, 2025
The impact of chiglitazar, a pan-PPAR agonist, on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: a real-world studyYijiong Tan, Wenjun Qu, Jiehua Zhao, et al.Life Sciences|November 21, 2024
USP13 ameliorates metabolic dysfunction-associated steatohepatitis through targeting PTENMin Tang, Xiaohui Wei, Yunqin Ma, et al.Metabolism: Clinical and Experimental|May 20, 2026
KCMF1 promotes MASLD progression via K48-linked ubiquitination and degradation of AMPKαMin Tang, Yunqin Ma, Jiaqi Wang, et al.Pageof 1